ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer.
Br J Cancer
; 119(3): 323-329, 2018 08.
Article
in En
| MEDLINE
| ID: mdl-29988110
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Neoplastic Syndromes, Hereditary
/
Brain Neoplasms
/
Colorectal Neoplasms
/
Proto-Oncogene Proteins B-raf
/
Mitogen-Activated Protein Kinase 3
/
P38 Mitogen-Activated Protein Kinases
Type of study:
Prognostic_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Br J Cancer
Year:
2018
Type:
Article
Affiliation country:
United kingdom